You are here: Home Products illumina Reseach


An expanding next-generation sequencing (NGS) oncology portfolio is helping Illumina drive the revolution in cancer genomics. Our NGS and microarray technologies are among the most trusted in the world. Our sample-to-data solutions deliver high-quality, reproducible results to speed the discovery and analysis of cancer-related variants—and potentially transform the cancer care cycle.

We’re committed to advancing and individualizing the way cancer will be identified and treated. We want to partner with you in helping propel progress in personalized oncology. Together we can work toward achieving our ultimate goal: to make discoveries that will make a life-changing difference to cancer patients and their loved ones.




Characterize un-culturable organisms. Discover entirely new viruses. Develop new strategies to control outbreaks. Monitor host-pathogen interactions.

Next-generation sequencing (NGS) is opening new doors in microbial genomics, revealing fresh insight into how microbes impact humans and the environment.


  • See how  NGS enables a broad range of microbial  studies. View Video.
  • Explore how Dr. Jennifer Gardy is using NGS to provide new clues to help prevent and control disease outbreaks. Read Article (PDF).
  • Learn how Dr. Ramunas Stepanauskas uses single-cell sequencing on Illumina systems to uncover hidden diversity and biogeographic variability in marine microorganisms. Read Case Study (PDF).

Through the power and high resolution of Illumina technology, you can now understand the genetic makeup of organisms that were previously impossible to study—helping you examine microbial biological functions, track genetic changes, rapidly respond to outbreaks, monitor food sources, and more.

See the bigger picture by examining the smallest details in the tiniest organisms with NGS. Learn more about how NGS can change your approach to microbiology.
Read Brochure (PDF).







Next-generation sequencing (NGS) enables researchers to better understand the biology that drives cancer predisposition and proliferation. These insights can support the development of targeted therapeutics and multi-analyte tumor analysis. NGS also opens the door for discovery of novel methods to monitor cancer treatment and recurrence.

lllumina brings innovation to cancer drug development by offering comprehensive genomic solutions and working in collaboration with leading pharmaceutical providers.


 complex disease

Complex diseases affect us all. Illumina is committed to advancing our understanding of complex diseases and how they will be diagnosed and treated.

Complex diseases result from a combination of genetic and environmental factors, many of which are not understood. These diseases include neurodegenerative, psychiatric, and autoimmune disorders, and others.

The expanding Illumina complex disease product portfolio includes array and next-generation sequencing (NGS) technologies that are helping drive a revolution in complex disease genomics. These solutions deliver high-quality, reproducible results that accelerate research on various complex diseases. These discoveries have the potential to lead to life-changing improvements for patients and their loved ones.  Clip




Exponential population growth and a changing climate create unique challenges for those working to maintain the food supply. To overcome this, many are turning to science. Agricultural genomics, or agrigenomics (the application of genomics in agriculture), has and will continue to help drive sustainable productivity and offer solutions to the mounting challenges of feeding the world’s growing population.

Through the constant development of new products and applications, Illumina is continually innovating ways to help agricultural researchers. Our agrigenomics technologies help plant and animal breeders and researchers identify desirable traits, leading to healthier and more productive crops and livestock.

Plant and Animal Genotyping

Today’s agricultural genomics researchers have many technologies at their disposal. Both array-based SNP genotyping and sequencing are used as discovery and screening tools to aid in breeding decisions.

Whether you are conducting a large-scale Genome-Wide Association Study (GWAS) or providing genetic services as part of a commercial laboratory, Illumina combines industry-leading data quality with the content flexibility to match any application.

Learn More
Plant and Animal Sequencing

Next-generation sequencing (NGS) is particularly useful in agricultural research, where genomes can be complex and prior knowledge scarce. NGS is also used to identify pathogens. It allows tracking of microbial or viral adaptation over short periods of time, both in the laboratory and in the environment.

Learn More

Our Partners


Bio-Active Co., Ltd. 
188/1 Bio-Active Bldg., Soi Sirung,
Chua Phloeng Rd., Chongnonsi,
Yannawa Bangkok 10120 



บริษัท ไบโอแอคทีฟ จำกัด
188/1 อาคารไบโอแอคทีฟ ซอยศรีรุ้ง
ถนนเชื้อเพลิง แขวงช่องนนทรี
เขตยานนาวา กรุงเทพฯ 10120


  • Hot line: 66-2350-3090
    FAX : 66-2350-3091


You are here: Home Products illumina Reseach